Find the Right GRC Solution

Search and compare GRC technology built for the problems you’re trying to solve

PRA Clarifies Process for Waivers, Modifications, and Rule Permissions Under FSMA and CRR Regulation

PRA Clarifies Process for Waivers, Modifications, and Rule Permissions Under FSMA and CRR Regulation

By
Regulatory data powered by Corlytics
The Prudential Regulation Authority (PRA) has published guidance on how firms apply for waivers, modifications, rule permissions (s138BA FSMA), and CRR permiss…
🔒
Cancel anytime
Full archive access
Custom alerts
Key Takeaways
  • The Prudential Regulation Authority (PRA) has published guidance on how firms apply for waivers, modifications, rule permissions (s138BA FSMA), and CRR permissions.
  • The guidance covers application content, assessment criteria, decision outcomes, renewal and revocation, and publication.
  • Compliance teams should confirm that internal procedures match these expectations, particularly the publication consent requirements and the accountable executive sign-off.
Deep Dive

The Prudential Regulation Authority (PRA) has published guidance on how firms apply for waivers, modifications, rule permissions (s138BA FSMA), and CRR permissions. The guidance covers application content, assessment criteria, decision outcomes, renewal and revocation, and publication. Compliance teams should confirm that internal procedures match these expectations, particularly the publication consent requirements and the accountable executive sign-off.

The guidance distinguishes three routes. A s138A waiver or modification applies to all PRA rules and requires the PRA to find that compliance would be unduly burdensome or would not achieve the rule's purpose, and that relief would not adversely affect any PRA objective. A s138BA rule permission is a defined concession or alternative prudential treatment with criteria set out in the Rulebook and in Statements of Policy (SoP). A CRR permission is a specific type of rule permission for banks and bank holding companies. It is governed by the CRR Regulations 2013 and s144G or s192XC FSMA. Where no permission-specific criteria exist, the PRA will place significant weight on the s138A tests. Applicants are encouraged to use the s138A route in that case. Conduct rules under s64A and the threshold condition code are excluded from the waiver and rule permission powers. Dual-regulated firms must apply directly to the FCA for relief from FCA rules.

Applications must be emailed to PRA-Waivers@bankofengland.co.uk and must include:
- the specific rules or CRR articles concerned
- all entities in the group requiring relief
- any linked FCA waivers
- any direction being renewed, and relevant precedents
- a clear rationale
- completed criteria and conditions forms
- a publication consent statement, or a substantive justification for non-publication
- key timelines
- confirmation of approval by relevant accountable executives

There are no statutory assessment deadlines. The PRA may not meet requested dates for complex applications, and it will consult the FCA where FCA solo-regulated firms or FCA objectives are affected. Firms may withdraw an application at any time before a decision. Modifications by Consent may be offered in exceptional circumstances to multiple firms, and a firm must email its agreement to the conditions to use one.

Approved relief is issued as a Direction or Written Notice. It states how the rule is modified, which entities are covered, the validity period, and any conditions such as new reporting. Relief is not retrospective. It is usually time-limited and requires a fresh application on expiry. Some relief, such as internal model use or alternative prudential regimes, may be indefinite while conditions continue to be met. The PRA may revoke relief at any time. Breaching a modified rule or a condition may lead to enforcement action and a possible s138D damages claim. Refusals include reasons. There is no Upper Tribunal referral right for s138A decisions, but one may exist for s138BA and CRR permission decisions.

The PRA has a statutory duty to publish approved relief unless it considers publication inappropriate or unnecessary. Most relief is published in full, some in abridged form. Firms seeking non-publication, abridged publication, or delayed publication must cite the relevant statutory provision (for example, Regulation 43 of the CRR Regulations 2013, s138B FSMA, or Reg 6 of the 2024 FSMA Regulations). If the PRA intends to publish against a firm's wishes, it will offer the chance to withdraw the application. Withheld items are reviewed over time, with representations allowed before any later publication. The consolidated waivers lists were current as of 1 August 2026, and the FCA Register is the primary data source.

Recommended actions:
- Inventory existing waivers, modifications, and permissions, with expiry dates and conditions, and build a renewal calendar that allows lead time given the lack of statutory deadlines.
- Update application templates to include entity lists, FCA linkage, publication positions, and executive sign-off.
- Establish monitoring of condition compliance, such as reporting obligations, to reduce enforcement and civil liability exposure.
- Assess early whether commercially sensitive relief warrants a non-publication case.
- Track reference numbers (application, transaction, and direction) for audit trails.

Risk implications: Reliance on expired, revoked, or breached relief creates prudential non-compliance and enforcement exposure. Publication of relief may reveal capital or liquidity treatments to the market. Delays in complex cases may affect business planning.

Source: Bank of England

Oops! Something went wrong